Clinical Trial Update: Evaluating Contrave for Weight Maintenance in Adults With BMI >= 27 Kg/m2, After 6 Month Behaviour Modification Program. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Contrave for weight maintenance in adults with BMI ≥27 after a 6-month behavioural modification program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CONTRAVE (bupropion/naltrexone)

Snippet

Sponsor: St. Joseph's Healthcare Hamilton | Conditions: Obesity | Phase 4 | Status: UNKNOWN